News
09-07-2013, 01:20 AM
The Pancreatic Cancer Action Network is pleased to announce that today ABRAXANE® was approved by the U.S. Food and Drug Administration (FDA) to treat metastatic pancreatic cancer.
More... (http://www.news-medical.net/news/20130907/FDA-approves-ABRAXANE-chemotherapy-drug-for-treatment-of-metastatic-pancreatic-cancer.aspx)
More... (http://www.news-medical.net/news/20130907/FDA-approves-ABRAXANE-chemotherapy-drug-for-treatment-of-metastatic-pancreatic-cancer.aspx)